Literature DB >> 30802004

A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis.

Lauren A Henderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30802004      PMCID： PMC6594873          DOI： 10.1002/art.40867

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  19 in total

1.  Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.

Authors:  Peter A Nigrovic; Melissa Mannion; Femke H M Prince; Andrew Zeft; C Egla Rabinovich; Marion A J van Rossum; Elisabetta Cortis; Manuela Pardeo; Paivi M Miettunen; Ginger Janow; James Birmingham; Aaron Eggebeen; Erin Janssen; Andrew I Shulman; Mary Beth Son; Sandy Hong; Karla Jones; Norman T Ilowite; Randy Q Cron; Gloria C Higgins
Journal:  Arthritis Rheum       Date:  2011-02

Review 2.  Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?

Authors:  Peter A Nigrovic
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

3.  Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis.

Authors:  Fabrizio De Benedetti; Hermine I Brunner; Nicolino Ruperto; Andrew Kenwright; Stephen Wright; Inmaculada Calvo; Ruben Cuttica; Angelo Ravelli; Rayfel Schneider; Patricia Woo; Carine Wouters; Ricardo Xavier; Lawrence Zemel; Eileen Baildam; Ruben Burgos-Vargas; Pavla Dolezalova; Stella M Garay; Rosa Merino; Rik Joos; Alexei Grom; Nico Wulffraat; Zbigniew Zuber; Francesco Zulian; Daniel Lovell; Alberto Martini
Journal:  N Engl J Med       Date:  2012-12-20       Impact factor: 91.245

4.  Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.

Authors:  F de Benedetti; M Massa; P Robbioni; A Ravelli; G R Burgio; A Martini
Journal:  Arthritis Rheum       Date:  1991-09

5.  Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.

Authors:  Jens Klotsche; Anna Raab; Martina Niewerth; Claudia Sengler; Gerd Ganser; Tilmann Kallinich; Tim Niehues; Markus Hufnagel; Angelika Thon; Toni Hospach; Gerd Horneff; Kirsten Minden
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

6.  Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Authors:  Yukiko Kimura; Jennifer E Weiss; Kathryn L Haroldson; Tzielan Lee; Marilynn Punaro; Sheila Oliveira; Egla Rabinovich; Meredith Riebschleger; Jordi Antón; Peter R Blier; Valeria Gerloni; Melissa M Hazen; Elizabeth Kessler; Karen Onel; Murray H Passo; Robert M Rennebohm; Carol A Wallace; Patricia Woo; Nico Wulffraat
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

7.  A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Authors:  Pierre Quartier; Florence Allantaz; Rolando Cimaz; Pascal Pillet; Claude Messiaen; Christophe Bardin; Xavier Bossuyt; Anne Boutten; Jacques Bienvenu; Agnes Duquesne; Olivier Richer; Damien Chaussabel; Agnes Mogenet; Jacques Banchereau; Jean-Marc Treluyer; Paul Landais; Virginia Pascual
Journal:  Ann Rheum Dis       Date:  2010-12-20       Impact factor: 19.103

8.  Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry.

Authors:  Gerd Horneff; Anna Carina Schulz; Jens Klotsche; Anton Hospach; Kirsten Minden; Ivan Foeldvari; Ralf Trauzeddel; Gerd Ganser; Frank Weller-Heinemann; Johannes Perter Haas
Journal:  Arthritis Res Ther       Date:  2017-11-22       Impact factor: 5.156

9.  Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany.

Authors:  Claas H Hinze; Dirk Holzinger; Elke Lainka; Johannes-Peter Haas; Fabian Speth; Tilmann Kallinich; Nikolaus Rieber; Markus Hufnagel; Annette F Jansson; Christian Hedrich; Hanna Winowski; Thomas Berger; Ivan Foeldvari; Gerd Ganser; Anton Hospach; Hans-Iko Huppertz; Kirsten Mönkemöller; Ulrich Neudorf; Elisabeth Weißbarth-Riedel; Helmut Wittkowski; Gerd Horneff; Dirk Foell
Journal:  Pediatr Rheumatol Online J       Date:  2018-01-22       Impact factor: 3.054

10.  Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis.

Authors:  Nicolino Ruperto; Hermine I Brunner; Pierre Quartier; Tamás Constantin; Nico Wulffraat; Gerd Horneff; Riva Brik; Liza McCann; Ozgur Kasapcopur; Lidia Rutkowska-Sak; Rayfel Schneider; Yackov Berkun; Inmaculada Calvo; Muferet Erguven; Laurence Goffin; Michael Hofer; Tilmann Kallinich; Sheila K Oliveira; Yosef Uziel; Stefania Viola; Kiran Nistala; Carine Wouters; Rolando Cimaz; Manuel A Ferrandiz; Berit Flato; Maria Luz Gamir; Isabelle Kone-Paut; Alexei Grom; Bo Magnusson; Seza Ozen; Flavio Sztajnbok; Karine Lheritier; Ken Abrams; Dennis Kim; Alberto Martini; Daniel J Lovell
Journal:  N Engl J Med       Date:  2012-12-20       Impact factor: 91.245
View more
  1 in total

1.  Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis - data from the German AID-registry.

Authors:  Elke Lainka; Melanie Baehr; Bernadette Raszka; Johannes-Peter Haas; Boris Hügle; Nadine Fischer; Dirk Foell; Claas Hinze; Elisabeth Weissbarth-Riedel; Tilmann Kallinich; Gerd Horneff; Daniel Windschall; Eggert Lilienthal; Tim Niehues; Ulrich Neudorf; Rainer Berendes; Rolf-Michael Küster; Prasad Thomas Oommen; Christoph Rietschel; Thomas Lutz; Frank Weller-Heinemann; Klaus Tenbrock; Georg Leonhard Heubner; Jens Klotsche; Helmut Wittkowski
Journal:  Pediatr Rheumatol Online J       Date:  2021-03-22       Impact factor: 3.054
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.